First of all, who the heck is Avisol Capital Partners? Frankly, just a bit sketchy: a couple of dudes in Indian that say they’re doctors with some financial staff to help them. Who knows what they are, really?
However, the one thing that these type of articles point out is the weakness in LP’s strategy to indefinitely withhold TLD because they need a Journal Article to fend off attacks against the results (and the company). Well, the longer they wait to release TLD, the more vulnerable the company becomes to negative sentiments, and likely from much more credible sources. The very thing that LP is trying to ostensibly prevent is exactly the kind of thing she’s creating.